Vmake Labs has officially rebranded from Vmake AI, aiming to revolutionize how brands and creators produce video content for social media. The new platform emphasizes a user-friendly experience that allows businesses to harness trending video styles to effectively showcase their products. This development is …
Weave's earnings per share of $0.04 aligned with consensus estimates, illustrating operational resilience despite a challenging market environment, where its shares are down 7.1% year-to-date.
The company’s earnings per share came in at $0.02, missing the $0.03 consensus estimate.
The company also posted second‑quarter revenue of $151.0 million, a 3% increase when stripped of a $1.6 million litigation settlement, while earnings per share came in at a loss of $‑0.14 versus a consensus estimate of $‑0.25. The guidance lift signals confidence in the …
Yelp Inc. (NYSE: YELP) achieved second-quarter revenue of $376 million, marking a 1% increase from the same period last year and exceeding the $8 million high end of its outlook. The reported earnings per share (EPS) stood at $0.62, significantly above the consensus estimate …
ProPhase Labs, Inc. (OTC: PRPH) has entered a significant financial arrangement with J.J. Astor & Co. securing a convertible loan valued at $2.08 million. The company received net proceeds of approximately $1.02 million after deducting fees.
Prothena (NASDAQ: PRTA) reported earnings per share of $‑0.32 for the quarter ended June 30, outpacing the $‑0.40 consensus and shrinking the quarterly net loss to $18.6 million. The result highlights a dramatic improvement from the $125.8 million loss recorded in the same quarter …
Prothena (NASDAQ: PRTA) reported earnings per share of $‑0.32 for the quarter ended June 30, outpacing the $‑0.40 consensus and shrinking the quarterly net loss to $18.6 million. The result highlights a dramatic improvement from the $125.8 million loss recorded in the same quarter …
The Trade Desk (NASDAQ: TTD) posted Q2 earnings per share of $0.34, which was below analyst expectations, while revenue rose modestly to $715 million, representing a 3% year-over-year increase. The company also used $78 million to repurchase a portion of its outstanding stock. These …
Pulse Biosciences, Inc. (NASDAQ: PLSE) has initiated a significant sales agreement that enables it to distribute shares worth up to $75 million. This agreement enhances the company's financial flexibility as it can tap the equity market to fund operations and growth initiatives. Optimal funding …